Patients with Obstructive Sleep Apnea and Cardiovascular Diseases: What, When, and Why Is Mandibular Advancement Device Treatment Required? A Short Review

Archive ouverte

François, Cindy | Bonafé, Arthur | Roubille, Camille | Roubille, François | Dupuy-Bonafé, Isabelle | Millot, Sarah

Edité par CCSD ; MDPI -

International audience. Obstructive sleep apnea is a potentially dangerous condition with significant risks of comorbidities if left untreated. It represents a cardiovascular risk factor in the general population, and a higher prevalence is observed in patients already suffering from cardiovascular diseases. The gold standard treatment, continuous positive airway pressure, is not always accepted or tolerated. The mandibular advancement device represents an alternative treatment that we propose to implement in our study. The objective here is to first present a brief review of the topic. Due to poor evidence in the field, we propose a pilot study to evaluate the effect of a mandibular advancement device in patients with cardiovascular disease who are not treated for their sleep pathology in order to improve their therapeutic management.

Suggestions

Du même auteur

Is hypertriglyceridemia atherogenic?

Archive ouverte | Huet, Fabien | CCSD

International audience. Purpose of review: Hypertriglyceridemia occurs mainly because of metabolic disorders secondary to diabetes, alcohol intake, and/or overweight. Genetic factors have also been clearly identifie...

Predicting One-Year Mortality after Discharge Using Acute Heart Failure Score (AHFS)

Archive ouverte | Magaldi, Mariarosaria | CCSD

International audience. Background: Acute heart failure (AHF) represents a leading cause of unscheduled hospital stays, frequent rehospitalisations, and mortality worldwide. The aim of our study was to develop a bed...

Coronavirus disease vaccination in heart failure: No time to waste

Archive ouverte | Roncalli, Jérôme | CCSD

International audience

Chargement des enrichissements...